Agilon Health, Inc. (AGL) – What Are Researchers Thinking About This Stock?

Agilon Health, Inc. (NYSE:AGL) has been given an average recommendation of “Hold” by the fifteen analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $102.25.

A number of research analysts have recently weighed in on the stock. Benchmark reissued a “buy” rating and set a $140.00 price objective (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and upped their target price for the company from $105.00 to $115.00 in a research note on Monday, August 10th. JPMorgan Chase & Co. upped their target price on Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and increased their target price for the company from $86.00 to $125.00 in a report on Tuesday, September 15th. Finally, Robert W. Baird set a $116.00 price target on Agilon Health in a report on Thursday, August 6th.

Institutional Trading of Agilon Health

Large investors have recently made changes to their positions in the stock. State Street Corp purchased a new stake in Agilon Health during the 2nd quarter worth about $30,024,000. The Manufacturers Life Insurance Company acquired a new position in Agilon Health in the 2nd quarter valued at about $355,000. Tidal Investments LLC purchased a new position in Agilon Health in the 2nd quarter valued at about $1,405,000. Engineers Gate Manager LP purchased a new position in Agilon Health in the 2nd quarter valued at about $516,000. Finally, Integrated Wealth Concepts LLC purchased a new position in Agilon Health in the 2nd quarter valued at about $384,000.

Agilon Health Stock Performance

NYSE:AGL opened at $82.86 on Tuesday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $1.39 billion, a P/E ratio of -5.81 and a beta of 2.98. The firm has a 50-day moving average price of $89.34 and a two-hundred day moving average price of $78.91. Agilon Health has a twelve month low of $7.48 and a twelve month high of $133.04.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.45 billion. As a group, research analysts expect that Agilon Health will post -2.90 earnings per share for the current fiscal year.

About Agilon Health

Agilon Health, Inc is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting.